Manisha Bansal | Medicinal Research | Best Researcher Award

Published on by Global Academic Awards

Assist. Prof. Dr. Manisha Bansal | Medicinal Research | Best Researcher Award

Punjabi University Patiala | India

Assist. Prof. Dr. Manisha Bansal serves as Assistant Professor (Stage III) in the Department of Chemistry, Punjabi University, Patiala, India. She holds a Ph.D. in Synthetic and Medicinal Chemistry with a thesis on antihypertensive agents and has over 17 years of teaching and 15 years of research experience. Her expertise lies in synthetic organic chemistry, medicinal chemistry, and photochemistry, with extensive work in drug design, molecular modeling, and bioactive compound synthesis. Assist. Prof. Dr. Manisha Bansal has published 20 research papers, accumulating 92 citations and an h-index of 6, with publications in reputed journals like Molecular Diversity, Bioorganic Chemistry, and Journal of Biomolecular Structure and Dynamics. She has guided multiple M.Phil. and Ph.D. scholars, presented at numerous national and international conferences, and contributed as a reviewer for leading journals. Her current research explores multi-targeted drug design against inflammatory, microbial, and cancer pathways.

Profile: Scopus | Orcid | Google Scholar

Featured Publications

1. Jain, R., & Bansal, M. (1995). A fascile synthesis and central nervous system activities of fluorine containing spiro-[3H-indole-3, 4′(4H)-pyran]-2 (1H)-ones. Pharmazie, 50(3), 224–225. (Cited by 18)

2. Kaur, G., Kaur, M., Sharad, L., & Bansal, M. (2020). Theoretical molecular predictions and antimicrobial activities of newly synthesized molecular hybrids of norfloxacin and ciprofloxacin. Journal of Heterocyclic Chemistry, 57(1), 225–237. (Cited by 13)

3. Bansal, M., & Kaur, R. (2015). Electromeric effect of substitution at 6th position in 2-(Furan-2-yl)-3-hydroxy-4H-chromen-4-one (FHC) on the absorption and emission spectra. Journal of Chemical Sciences, 127(3), 405–412. (Cited by 13)

4. Kaur, M., Rehman, H. M., Kaur, G., Kaur, A., & Bansal, M. (2023). Switching of newly synthesized linker-based derivatives of non-steroidal anti-inflammatory drugs toward anti-inflammatory and anticancer activity. Bioorganic Chemistry, 133, 106406. (Cited by 12)

5. Kaur, G., Kaur, M., & Bansal, M. (2021). New insights of structural activity relationship of curcumin and correlating their efficacy in anticancer studies with some other similar molecules. American Journal of Cancer Research, 11(8), 3755–3769. (Cited by 9)

 

Mohamed Abdelsalam | Interventional Radiology | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Mohamed Abdelsalam | Interventional Radiology | Best Researcher Award

The University of Texas MD Anderson Cancer center | United States

Assoc. Prof. Dr. Mohamed Abdelsalam is a highly accomplished Interventional Radiologist at The University of Texas MD Anderson Cancer Center, currently serving as Associate Professor after joining as Assistant Professor in 2016. He earned his MBBS (Magna Cum Laude) from Cairo University Faculty of Medicine and completed advanced training including a Clinical Residency in Diagnostic Radiology and a Clinical Fellowship in Vascular Interventional Radiology at MD Anderson. Assoc. Prof. Dr. Mohamed Abdelsalam has extensive professional experience, including roles as Visiting Scientist, Assistant Lecturer, and Assistant Medical Director at Cairo University and affiliated institutions. He is board-certified in Diagnostic and Interventional Radiology and holds multiple DEA and Texas Medical Board licenses. His research focuses on image-guided oncologic interventions, vascular procedures, and minimally invasive cancer therapies, with notable contributions in radiofrequency ablation, thrombectomy, and renal tumor management. With 37 Scopus-indexed publications, 288 citations, and an h-index of 11, he has received several honors, including Teaching IR Physician of the Year (2020) and Distinguished Abstract Award (SIR, 2013), reflecting his impact in both clinical practice and research.

Profile: Scopus

Featured Publications

  • Abdelsalam, M. E., et al. (2025). Technical effectiveness and clinical outcomes of mechanical thrombectomy in cancer patients presenting with IVC filter–associated deep venous thrombosis: A retrospective study. Annals of Vascular Surgery.

  • Abdelsalam, M. E., et al. (2025). Cystoscope assisted trans-conduit removal of fragmented percutaneous nephrostomy catheter. Urology Case Reports.

  • Abdelsalam, M. E., et al. (2025). Technique and outcomes of radiofrequency ablation of biopsy-proven 3–4 cm T1a renal cell carcinoma. Biomedicines.

Dipen Patel | Internal Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Dipen Patel | Internal Medicine | Best Researcher Award

The Ohio State University Comprehensive Cancer Center | United States

Dr. Dipen Patel, Assistant Professor in the Division of Medical Oncology at The Ohio State University Comprehensive Cancer Center, is an accomplished clinician-researcher specializing in neuroendocrine and thyroid malignancies. His research emphasizes innovative diagnostic and therapeutic strategies, including targeting anti-apoptotic pathways, immunotherapy for anaplastic thyroid cancer, and multidisciplinary management of advanced thyroid and neuroendocrine tumors. Dr. Patel has an extensive publication record with impactful articles in Endocrine Practice, Annals of Surgical Oncology, Thyroid, and Endocrine-Related Cancer, alongside numerous abstracts and presentations at ASCO, NANETS, ENETS, and ACG, highlighting translational relevance that bridges clinical care and research. With a documented h-index of 1, three scholarly documents, and one citation, his work demonstrates growing influence in the field, establishing him as a strong candidate for the Best Researcher Award.

Profile: Scopus

Featured Publications

Patel, D., Sukrithan, V., Ahmed, U., Krause, H., Gandhi, N., Elliott, A., Hinton, A., Walker, P., Vanderwalde, A., Zhou, Y., Lou, E., Soares, H. P., Rogers, K. A., & Konda, B. (2025). Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasms. Endocrine-Related Cancer, 32(7), e240341.

Ehsan Ghasemi | Physiotherapy | Best Researcher Award

Published on by Global Academic Awards

Assist. Prof. Dr. Ehsan Ghasemi | Physiotherapy | Best Researcher Award

Isfahan University of Medical Sciences | Iran

Assist. Prof. Dr. Ehsan Ghasemi, PhD, Assistant Professor at Isfahan Medical Sciences, has an extensive and impactful research portfolio in neurological rehabilitation, focusing on stroke, multiple sclerosis, and gait and balance disorders. With 38 citations, 7 key publications, and an h-index of 3, his work demonstrates a strong influence on both clinical practice and scientific advancement. His research includes innovative clinical trials exploring the effects of functional stretching exercises, neuromuscular stabilization, and virtual reality interventions, including Nintendo Wii-based rehabilitation, on neural and mechanical parameters in patients with spasticity and balance impairments. Assist. Prof. Dr. Ehsan Ghasemi combines rigorous clinical research with practical physiotherapy applications, enhancing patient outcomes while advancing scientific knowledge. In addition to research, he is an experienced educator in exercise therapy, neurological physiotherapy, and evidence-based practice, mentoring students and clinicians. His active participation in national and international conferences further highlights his dedication to knowledge dissemination and professional development in the field of neurorehabilitation.

Profile: Scopus | Orcid | Google Scholar

Featured Publications

Ghasemi, E., Khademi-Kalantari, K., Khalkhali-Zavieh, M., Rezasoltani, A., … (2018). The effect of functional stretching exercises on functional outcomes in spastic stroke patients: A randomized controlled clinical trial. Journal of Bodywork and Movement Therapies, 22(4), 1004–1012.

Ghasemi, E., Khademi-Kalantari, K., Khalkhali-Zavieh, M., Rezasoltani, A., … (2018). The effect of functional stretching exercises on neural and mechanical properties of the spastic medial gastrocnemius muscle in patients with chronic stroke: A randomized controlled trial. Journal of Stroke and Cerebrovascular Diseases, 27(7), 1733–1742.

Ghasemi, E., Shaygannejad, V., Ashtari, F., Fazilati, E., & Fani, M. (2008). The investigation of Frenkel’s exercises effect on ataxia, balance, activity of daily living, and depression in patients with multiple sclerosis. Journal of Research in Rehabilitation Sciences, 4(1), 21–28.

Ghasemi, E., Shaygannejad, V., Ashtari, F., & Chitsaz, A. (2011). The effectiveness of Frenkel’s and Swiss ball exercises on improved balance and decreased depression in patients with multiple sclerosis: A comparative study. Journal of Research in Rehabilitation Sciences, 7(3), 278–283.

Ghasemi, E., Shaygannejad, V., Ashtari, F., Mordi, B., & … (2010). An investigation on the effects of neuromuscular exercise on balance, gait, and depression of patients with multiple sclerosis. Journal of Research in Rehabilitation Sciences, 7(2), 149–154.

Prof. Dr. Luis F B B Feitoza | Clinical Sciences | Best Researcher Award

Published on by Global Academic Awards

Prof. Dr. Luis Felipe Feitoza | Clinical Sciences | Best Researcher Award

Prof. Dr. Luis Felipe Feitoza, Kansas State University, United States

Dr. Luis Feitoza is a seasoned veterinarian and academic with a PhD in Veterinary Medicine & Pathobiology. 🐄 He specializes in bovine diagnostics, ruminant nutrition, and feedlot management. 🇺🇸🇧🇷 Trained in Brazil and the U.S., he has served as a Clinical Assistant Professor and research consultant, mentoring graduate students and leading veterinary research. 📊 He’s published on cardiac physiology and drug toxicity, and holds certifications in veterinary ultrasound and data analytics. 🏆 Awarded for both scientific and wildlife photography, he’s also a licensed drone pilot and multilingual communicator.

Publication Profile

Orcid

Google Scholar

🎓 Educational Background

Prof. Dr. Luis F.B.B. Feitoza holds a PhD in Veterinary Medicine & Pathobiology (2023–2024) from Kansas State University 🐄, focusing on veterinary diagnostics and ruminant nutrition. He also earned a Graduate Certificate in Applied Statistics (2018–2022) 📊 and pursued doctoral studies in Animal Sciences emphasizing beef cattle nutrition. Earlier, he received his DVM from the Federal Rural University of Rio de Janeiro (2012–2017) 🇧🇷. Dr. Feitoza also trained at UC Davis in muscle physiology 🧬 and was a visiting scholar at the University of Wisconsin-River Falls (2014–2015) 🇺🇸, where he also completed an English language program

🔬 Research & Work Experience

Prof. Dr. Luis F.B.B. Feitoza currently serves as Graduate School Faculty and Clinical Assistant Professor at the Beef Cattle Institute, Kansas State University 🐂 (2024–present), where he teaches bovine medicine and manages the Feedlot Clinical Rotation. Since 2017, he has worked as a Veterinary Research Consultant across Brazil and the USA 🌎, focusing on herd health, ultrasound diagnostics, and interdisciplinary R&D projects. His previous roles include Research Assistant and Doctorate Researcher (2023–2024), conducting clinical trials, laboratory assays, and data analysis 🔬📈. His work bridges diagnostics, internal medicine, and animal health innovation.

📚 Teaching Experience

Prof. Dr. Luis F.B.B. Feitoza has an extensive teaching background in veterinary and animal sciences 🐄. In 2025, he coordinated the Feedlot Clinical Rotation and lectured on agricultural communication at Kansas State University 🎓. His earlier roles as a Teaching Assistant included Equine Exercise Physiology and Horse Science (2019), where he focused on muscle physiology and equine nutrition 🐎. He also contributed to undergraduate research training (2018) and taught Animal Physiology at UFRRJ in Brazil (2013–2017) 🧬. His hands-on, student-focused approach emphasizes clinical knowledge, research skills, and cross-cultural communication.

🏆 Awards & Recognitions

Prof. Dr. Luis F.B.B. Feitoza has earned multiple accolades recognizing both his scientific and creative contributions 🎖️. He won first place at the IV Annual Meeting of Scientific Initiation (2016) for his work on maternal diet and offspring heart health 🫀. In 2014, he received Honorable Mention at the I Panamerican Congress of Physiological Sciences for research on cardiac adrenoreceptor expression in rats 🧪. Additionally, his photography earned him first and second place awards in the “Outdoor Recreation” and “Other Species” categories in Wild about Kansas by Kansas Wildlife Magazine in 2018

🔬 Research Focus

Prof. Dr. Luis F.B.B. Feitoza’s research spans across veterinary diagnostics, cardiotoxicology, ruminant nutrition, and parasitology 🐄🧬. His work includes studying drug-induced cardiac dysfunction using proteasome and mitochondrial pathways 🫀🧪, nutritional strategies like molasses-based supplementation to improve cattle health 🌾🥩, and parasitic infestations in exotic and wild animals, including first reports of tick species on emus 🦠🦢. He integrates statistical modeling, field diagnostics, and clinical trials to investigate animal health and performance. His interdisciplinary approach bridges veterinary science, physiology, and livestock management, making his research crucial for both animal welfare and agricultural efficiency

Publication Top Notes

📖 Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts – International Journal of Cardiology, 📅 2016 | 🔗 DOI: 10.1016/j.ijcard.2016.08.233 | 📥 Cited by: 77
💊🧬🫀

📖 Ticks in wild animals at a resort and the first documentation of Amblyomma sculptum infesting Emu (Dromaius novaehollandiae) – Revista Brasileira de Parasitologia Veterinária, 📅 2019 | 🔗 DOI: 10.1590/s1984-296120180082 | 📥 Cited by: 9
🦠🦙🌿

📖 PSII-3 Effect of molasses-based block supplementation on cattle fed endophyte-infected Tall Fescue (Festuca arundinacea) seed – Journal of Animal Science, 📅 2019 | 🔗 DOI: 10.1093/jas/skz122.400

📖 Effect of Molasses-Based Block Supplementation on Performance and Welfare of Cattle Fed Infected Tall Fescue seed – Journal article, 📅 2019 | 🔗 DOI: 10.13140/RG.2.2.27430.37442/1

📖 Associations Between Thoracic Ultrasound Chute-Side Evaluations and 60-Day Outcomes in Feedyard Cattle – Veterinary Sciences, 📅 2025 | 🔗 DOI: 10.3390/vetsci12040369

📖 Molasses-Based Block Supplements for Cattle Fed Endophyte-Infected Tall Fescue: Growth & Biomarkers – Animals, 📅 2025 | 🔗 DOI: 10.3390/ani15050717

📖 Targeted durations of tylosin phosphate on liver abscesses in feedlot cattle – Applied Animal Science, 📅 2025 | 🔗 DOI: 10.15232/aas.2024-02574

📖 Targeted thoracic ultrasonography for diagnosing interstitial pneumonia in feedyard cattle – American Journal of Veterinary Research, 📅 2025 | 🔗 DOI: 10.2460/ajvr.24.08.0233

📖 Thoracic Ultrasound in Cattle: Methods, Diagnostics, and Prognostics – Veterinary Sciences, 📅 2025

📖 greatOplus (Extruded Flaxseed & Nannochloropsis) Improves Cattle Performance – KAES Research Reports, 📅 2025

📖 Histologic Characterization of Pulmonary Lesions in Feedlot Cattle Mortalities – Conference Poster, 📅 2024 | 🔗 DOI: 10.13140/RG.2.2.25296.21766

📖 Viability of drone mapping in artisanal fisheries – Sepetiba Bay, Brazil – Ciência Rural, 📅 2024 | 🔗 DOI: 10.1590/0103-8478cr20230167

Shixun Wang | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Dr. Shixun Wang | Cardiology | Best Researcher Award

Professor at Weifang People’s Hospital, China

Dr. Wang Shixun 👨‍⚕️, born in October 1979, is a distinguished cardiovascular specialist at Weifang People’s Hospital. He earned his doctorate in Cardiovascular Medicine from Weifang Medical College in 2006 and has over 18 years of clinical experience. Currently serving as Deputy Director, he is applying for the position of Chief Physician 👨‍🔬. Known for his excellence in clinical practice, he received top evaluation ratings from 2018 to 2021 🌟. Dr. Wang demonstrates strong computer and foreign language skills 💻🗣️ and is highly respected for his dedication to cardiovascular care and hospital leadership ❤️🏥.

Publication Profile

Scopus

Orcid

Academic Background

Dr. Wang Shixun 👨‍⚕️ graduated from Weifang Medical College in July 2006 🎓, earning his doctorate in Cardiovascular Medicine ❤️. Immediately after graduation, he began his medical career at Weifang People’s Hospital 🏥, demonstrating a seamless transition from academic training to clinical practice. With a strong foundation in medical education and a passion for patient care 💉, Dr. Wang quickly established himself as a dedicated healthcare professional. His long-term commitment to the same institution reflects both loyalty and deep institutional knowledge 📘, making him a valuable asset to the hospital and the broader medical community 🌟.

Professional Experience

Dr. Wang Shixun 👨‍⚕️ obtained his current professional and technical qualifications in March 2017 and has since shown remarkable growth in the field of Cardiovascular Medicine ❤️. He was first appointed to his current role in September 2018 and has accumulated five years of dedicated service in this position. Dr. Wang now applies for the title of Chief Physician, reflecting his advanced clinical expertise and leadership readiness 🧠. He also serves as Deputy Director 🏥, balancing administrative responsibilities with medical duties. Additionally, he has demonstrated proficiency in computer applications 💻, enhancing his effectiveness in modern healthcare delivery.

Awards and Honors

Dr. Wang Shixun 👨‍⚕️ has consistently demonstrated excellence in his medical career, earning outstanding performance evaluations for four consecutive years—2018, 2019, 2020, and 2021 🏅. These “Excellent” ratings reflect his dedication, clinical skill, and strong work ethic in the field of Cardiovascular Medicine ❤️. In 2022, he continued to maintain a high standard with a “Qualified” rating ✅. His consistent recognition by peers and superiors underscores his commitment to medical excellence and patient care 🙌. These honors highlight Dr. Wang’s growing influence and leadership within the hospital and the broader medical community 🏥✨.

Research Focus

Dr. Wang Shixun 👨‍⚕️ is deeply engaged in the field of Cardiovascular Medicine, with a strong focus on clinical research aimed at improving patient outcomes and advancing treatment strategies for heart-related conditions ❤️🫀. His work emphasizes evidence-based practices, integrating the latest medical advancements into routine care 🧬📊. As Deputy Director at Weifang People’s Hospital 🏥, he actively participates in research initiatives and fosters a collaborative environment for innovation and knowledge sharing 🤝💡. With his solid academic foundation and practical experience, Dr. Wang continues to explore new frontiers in cardiovascular healthcare to benefit patients and the medical community 🌍📚.

Publication Top Notes

📝 A Case of Treatment With a Combination of Covered Stents and Artificial Blood Vessel for Iliac Artery Rupture During Transcatheter Aortic Valve Replacement

📅 Year: 2025 | 📚 Journal: Clinical Case Reports

Efficacy and Safety of Different Dosing Regimens of Colchicine in Patients with Coronary Artery Disease: A Network Meta-analysis of 15 Randomized Controlled Trials

Effect of levocarnitine on TIMP-1, ICAM-1 expression of rats with coronary heart disease and its myocardial protection effect

Serum Amyloid a Promotes Visfatin Expression in Macrophages

Plumbagin mediates cardioprotection against myocardial ischemia/reperfusion injury through Nrf-2 signaling

Conclusion

Dr. Wang Shixun is a highly skilled and experienced medical professional in the field of Cardiovascular Medicine, currently serving as Deputy Director at Weifang People’s Hospital and applying for the position of Chief Physician. With a doctoral degree and nearly two decades of clinical service since 2006, he has consistently demonstrated excellence, as reflected in multiple years of outstanding evaluations. He also shows proficiency in foreign languages and computer applications. However, while his clinical credentials and leadership are commendable, there is currently limited evidence of significant research contributions—such as peer-reviewed publications, funded projects, or academic impact—needed to support a strong case for a Best Researcher Award.

Jiaqi Lou | Clinical medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Jiaqi Lou | Clinical medicine | Best Researcher Award

Dr. Jiaqi Lou, Ningbo No.2 Hospital, China

Lou Jiaqi, born on May 16, 1995, is a dedicated burn surgeon and researcher specializing in intestinal mucosal healing post-burn injury. He holds a Master’s degree in Burns/Surgery from Xuzhou Medical University (2019-2022) and a Bachelor’s degree in Clinical Medicine from Wenzhou Medical University Renji College (2013-2018). Currently, he serves as a Resident at Ningbo No.2 Hospital’s Department of Burns. His research focuses on circular and long non-coding RNAs in burn-induced intestinal damage, nutritional strategies for burn patients, and predictive modeling in burn care. With multiple publications in high-impact journals like Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology, he has significantly contributed to advancing burn treatment methodologies. Proficient in molecular biology and bioinformatics, he actively integrates clinical practice with translational research, enhancing patient outcomes. His expertise extends to animal models, clinical nutrition, and machine learning applications in burn medicine.

Publication Profile

Scopus

Orcid

Education 🎓📚

Lou Jiaqi pursued his Bachelor’s degree in Clinical Medicine at Wenzhou Medical University Renji College (2013-2018), where he gained a solid foundation in medical sciences and clinical practice. Following this, he completed his Master’s degree in Burns/Surgery at Xuzhou Medical University (2019-2022), focusing on post-burn intestinal mucosal healing and advanced molecular techniques. His postgraduate research centered on exploring the role of circular RNAs and long non-coding RNAs in burn-induced intestinal injury, utilizing qRT-PCR, bioinformatics analysis, and adenoviral transfection techniques. He also conducted extensive studies on enteral and parenteral nutrition strategies for burn patients, integrating randomized controlled trials and systematic reviews. Throughout his academic journey, he actively engaged in laboratory and clinical research, refining his expertise in molecular biology, protein interactions, and animal modeling. His strong academic background, combined with hands-on research and clinical exposure, has shaped him into a proficient clinician-scientist in burn medicine.

Experience 🏥

Lou Jiaqi is a Resident at the Department of Burns, Ningbo No.2 Hospital (2022-present), where he manages burn patient care and conducts translational research. Previously, he served as a Resident at The Affiliated Huaihai Hospital of Xuzhou Medical University and The 71st Group Army Hospital of PLA (2019-2022), gaining extensive experience in burn surgery and post-burn recovery. His clinical training began with rotations at leading hospitals, including Minhang Hospital and The First Affiliated Hospital of Wenzhou Medical University (2016-2018). During his early medical career, he interned at Ningbo No.1 Hospital’s Burn Department, refining his hands-on patient care and surgical skills. His experience spans acute burn management, surgical interventions, intensive care, and nutritional strategies for burn patients. Alongside his clinical duties, he integrates machine learning and predictive modeling to enhance patient outcomes, positioning himself at the forefront of innovative burn treatment methodologies.

Awards & Honors 🏆🎖️

Lou Jiaqi has received several accolades for his contributions to burn medicine and research. He was awarded the Certificate of Resident Standardization Training of China (2024), recognizing his advanced clinical expertise. His achievements in molecular biology and burn research have been acknowledged through multiple journal publications, including in Cell Biology International, Cell Death & Disease, and Burns & Trauma. He obtained the Medical Practitioners Qualification of China (2021) and the Basic Life Support Provider Certification (2022), demonstrating his commitment to patient safety and professional excellence. His studies on burn-induced intestinal injury and nutritional optimization in burn patients have earned him recognition in both national and international medical communities. With a strong research background, he has contributed to advancements in RNA-based therapies and predictive modeling, enhancing patient outcomes. His extensive training, combined with a passion for innovation, has solidified his reputation as a promising burn surgeon and scientist.

Research Focus 🔬🧬

Lou Jiaqi specializes in burn-induced intestinal mucosal healing, investigating the role of circular and long non-coding RNAs in post-burn intestinal injury. His research includes circRNA-mediated signaling pathways, ceRNA network modeling, and RNA-binding protein interactions to enhance tissue repair mechanisms. He has explored enteral and parenteral nutritional strategies to optimize burn patient recovery, conducting randomized controlled trials and systematic reviews. His expertise extends to molecular and cellular techniques such as qRT-PCR, Western blotting, ELISA, and dual-luciferase assays. Additionally, he applies machine learning and Mendelian randomization in predictive modeling for burn patient outcomes. His studies have led to significant publications in Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology. By integrating basic science, clinical practice, and bioinformatics, he contributes to innovative therapeutic approaches in burn care, focusing on translational medicine and personalized treatment strategies for severe burn patients.

 

Publication Top Notes

  • “A Bidirectional Mendelian-Randomization Analyses of Genetically Predicted Circulating Levels of Systemic Inflammatory Regulators with Risk of Sepsis” (2024) examines genetic predictors of systemic inflammation and their association with sepsis risk.

    ACM Digital Library

  • “Development, Reliability, and Validity of the Second-Modified Nutrition Risk Screening 2002” (2024) focuses on enhancing nutritional risk screening tools for clinical settings.

    ACM Digital Library

  • “The Efficacy and Safety of Negative Pressure Wound Therapy in Paediatric Burns: A Systematic Review and Meta-Analysis of Randomized Controlled Trials” (2024) evaluates the effectiveness of negative pressure wound therapy in treating pediatric burn patients.

    ACM Digital Library

  • “A Two-Step, Two-Sample Mendelian Randomization Analysis Investigating the Interplay Between Gut Microbiota, Immune Cells, and Melanoma Skin Cancer” (2024) investigates the relationship between gut microbiota, immune response, and melanoma development.

    ACM Digital Library

  • “A Retrospective Study Utilizing MIMIC-IV Database to Explore the Potential Association Between Triglyceride-Glucose Index and Mortality in Critically Ill Patients with Sepsis” (2024) explores the link between triglyceride-glucose index levels and mortality rates in septic patients.

    ACM Digital Library

  • “Effects of Virtual Reality on Analgesia in Wound Care and Physical Therapy for Burn Patients: A Systematic Review and Meta-Analysis” (2024) assesses the use of virtual reality for pain management in burn care.

    ACM Digital Library

  • “Development and Validation of a Nomogram to Predict Hypothermia in Adult Burn Patients During Escharectomy Under General Anesthesia” (2024) introduces a predictive tool for hypothermia during specific surgical procedures in burn patients.

    ACM Digital Library

  • “Efficacy of Probiotics or Synbiotics in Critically Ill Patients: A Systematic Review and Meta-Analysis” (2024) examines the benefits of probiotics or synbiotics in critically ill patients.

    ACM Digital Library

  • “Causal Relationship Between the Gut Microbiome and Basal Cell Carcinoma, Melanoma Skin Cancer, Ease of Skin Tanning: Evidence from Three Two-Sample Mendelian Randomisation Studies” (2024) explores the causal links between the gut microbiome and various skin conditions.

    ACM Digital Library

  • “PRP8-Induced CircMaml2 Facilitates the Healing of the Intestinal Mucosa via Recruiting PTBP1 and Regulating Sec62” (2022) investigates molecular mechanisms involved in intestinal mucosal healing.

    ACM Digital Library

 

 

Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Published on by Global Academic Awards

Prof. Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Prof. Fatmah Alasmary, Saudi Food and Drug Authority, Saudi Arabia

Professor at King Saud University, specializing in organic chemistry. Dr. Alasmary has extensive experience in academia and leadership, with a PhD from the University of Bradford. Currently, she serves as Director of the Drug Lab at the Saudi Food and Drug Authority. Her research interests include antimicrobial agents and nanomaterials. Dr. Alasmary has mentored numerous students and has held key roles in various scientific committees. She is a member of the Saudi Chemical Association, the Royal Society of Chemistry, and the American Chemical Society. 🧑‍🔬👩‍🏫🔬

Publication Profile

Google Scholar

Work Experience 🌍💼

Prof. Fatmahalasmary is a distinguished academic and professional, currently serving as the Director of Drug Lab at Saudi Food and Drug Authority, Riyadh. She oversees quality control, safety standards, and international accreditation efforts for medicines and cosmetics. As Chief of Senior Expert International Communication, she leads food standards initiatives for Saudi Arabia, managing ISO committees and Codex committees. Previously, she was Vice Chairman at King Saud University’s Chemistry Department, coordinating research, teaching, and international collaborations. Prof. Fatmahalasmary’s leadership spans teaching, curriculum development, and guiding postgraduate research, exemplifying excellence in both academic and professional spheres. 📚🌐👩‍🔬

 

Qualifications 🎓🌟

Prof. Fatmahalasmary holds a PhD in Chemistry from the University of Bradford, England (2013), where her thesis focused on the synthesis and evaluation of benzimidazole derivatives as potential antimicrobial agents. She earned a Master of Science in Chemistry from King Saud University, KSA (2008), with a thesis on the synthesis and study of quinoxaline derivatives. Additionally, she completed her Bachelor of Science in Chemistry at King Saud University, KSA (2001), graduating with honors. Her academic journey highlights a strong foundation in chemistry and a commitment to research excellence. 🧪📘👩‍🔬

 

Additional Experience 🌍🔬

Prof. Fatmahalasmary has actively participated in over 22 workshops focused on management, planning, and quality development. She is a member of several prestigious associations, including the Saudi Chemical Association, Royal Society of Chemistry, and American Chemical Society. Her roles have included coordinating committees at King Saud University (KSU), such as the Development and Quality Committee and Labs Committee. Prof. Fatmahalasmary has also been involved in thesis defenses, scientific symposia, and national exhibitions. She holds patents for innovative extracts and is certified in ISO 9001:2015 and as a Certified Innovation Professional. 📚💡📈

 

Research Focus

Prof. Fatmah Ali S Alasmary’s research spans various fields, including antimicrobial agents 🦠, biological chemistry 🧬, and medicinal chemistry 💊. She has contributed significantly to the development of benzimidazole derivatives as potential antimicrobial agents, as well as carbonic anhydrase inhibitors targeting various pathogens. Her work also delves into perovskite materials 🏗️, photocatalysis ⚛️, and nanomaterials 🧪 with applications in sensing and biomedical fields. Prof. Alasmary has been actively involved in computational studies of drug design 💻, enzyme inhibition 🧪, and therapeutic applications for diseases like malaria and cancer.

 

Publication Top Notes  

  • Tin versus lead redox chemistry modulates charge trapping and self-doping in tin/lead iodide perovskites (186 citations, 2020) 🔋
  • Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents (140 citations, 2015) 💊
  • Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates (41 citations, 2017) 🦠
  • Direct Access to α‐Aminosilanes Enabled by Visible‐Light‐Mediated Multicomponent Radical Cross‐Coupling (36 citations, 2021) 💡
  • Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3 H)-ones as … (35 citations, 2015) 🔬
  • Analysis of Alpina officinarum Hance, chemically and biologically (30 citations, 2019) 🌿
  • Combined computational and experimental investigation on the nature of hydrated iodoplumbate complexes: Insights into the dual role of water in perovskite precursor solutions (28 citations, 2020) 💧
  • The first activation studies of the η-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids (28 citations, 2018) 🦠
  • New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase (28 citations, 2017) 🧪
  • Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach (27 citations, 2021) 🦠

 

Francesca Borgnis | Teleriabilitazione | Best Researcher Award

Published on by Global Academic Awards

Dr. Francesca Borgnis | Teleriabilitazione | Best Researcher Award

Dr. Francesca Borgnis, IRCCS Fondazione Don Carlo Gnocchi ONLUS, Italy

Dr. Francesca Borgnis is a distinguished Italian researcher specializing in psychology, telerehabilitation, and digital health interventions. She earned her Ph.D. in Psychology from the Catholic University of Sacred Heart, Italy (2019–2023), and currently serves as a researcher at the S. Maria Nascente IRCCS Fondazione Don Carlo Gnocchi ONLUS. Her work focuses on innovative treatments, including digital therapeutics for chronic neurological disorders, and she has collaborated on numerous grants and projects, such as SIDERA^B and DANCEREX. Dr. Borgnis has authored 31 publications, contributing significantly to cognitive rehabilitation, telerehabilitation, and assistive technology research. She also lectures on developmental and educational psychology at Università degli Studi di Milano. 🌐🧠📚

 

Publication Profile

Orcid

Google Scholar

Academic Journey

Dr. Francesca Borgnis is a dedicated scholar with extensive expertise in psychology. She earned her Ph.D. in Psychology from the Catholic University of Sacred Heart, Italy (2019–2023). Before this, she qualified in Psychology through the University of Pavia in 2018. Dr. Borgnis gained valuable clinical experience during her internship at the MRI Lab & Neuropsychology Clinic at S. Maria Nascente, IRCCS Fondazione Don Carlo Gnocchi ONLUS, Italy. She holds a Master’s degree in Clinical, Developmental Psychology, and Neuropsychology (2017) and a Bachelor’s in Psychology (2015), both from the University of Milan-Bicocca. 🧠📚

 

Teaching Activities

Dr. Francesca Borgnis is an accomplished lecturer specializing in developmental and educational psychology. Since 2023, she has been sharing her expertise with students at Università degli Studi di Milano, Italy. Her teaching focuses on fostering a deep understanding of psychological development and its applications in educational settings. With a passion for empowering future professionals, Dr. Borgnis integrates her academic and clinical experience into engaging and insightful lectures. Her dedication to teaching reflects her commitment to advancing knowledge in psychology and inspiring the next generation of scholars. 🎓👩‍🏫

 

Professional Engagements

Dr. Francesca Borgnis actively contributes to the academic and research community through her role as a Member of the Advisory Board Giovani Ricercatori at Fondazione Don Gnocchi ONLUS, a position she has held since 2024. In this capacity, she collaborates with fellow researchers to foster innovation and support young investigators in their academic journeys. Dr. Borgnis is dedicated to building networks within scientific societies and promoting interdisciplinary collaboration. Her involvement in this advisory role underscores her commitment to advancing research excellence and nurturing the next generation of scholars. 🤝🧠✨

 

🎯 Research Focus

Dr. Francesca Borgnis specializes in innovative approaches to cognitive and neuropsychological assessment, with a strong emphasis on virtual reality (VR) and telerehabilitation. Her research explores the role of mirror neurons in neurodegenerative disorders 🧠, VR-based tools for evaluating executive functions 🎮, and the use of 360° technology for memory and cognitive assessments. Dr. Borgnis has contributed to studies on Parkinson’s disease, Alzheimer’s disease, and chronic disabilities, focusing on digital health interventions and assistive technologies 🤖. Her work integrates systematic reviews, meta-analyses, and cutting-edge methodologies to enhance patient rehabilitation and assessment in clinical neuropsychology. ✨📊

 

Publication Top Notes  

📚 Mirror neurons and their relationship with neurodegenerative disorders
🖋️ E Farina, F Borgnis, T Pozzo
📅 2020 | 🔗 Cited by: 49

🌐 Available virtual reality-based tools for executive functions: a systematic review
🖋️ F Borgnis, F Baglio, E Pedroli, et al.
📅 2022 | 🔗 Cited by: 45

🧠 The use of a virtual reality platform for memory decline and hippocampal neural injury in mild cognitive impairment
🖋️ M Cabinio, F Rossetto, S Isernia, et al.
📅 2020 | 🔗 Cited by: 35

💻 Telerehabilitation approaches for chronic heart failure: a systematic review and meta-analysis
🖋️ S Isernia, C Pagliari, N Morici, et al.
📅 2022 | 🔗 Cited by: 20

🌬️ Characteristics and efficacy of telerehabilitation for chronic obstructive pulmonary disease
🖋️ S Isernia, C Pagliari, LNC Bianchi, et al.
📅 2022 | 🔗 Cited by: 19

🧪 Digital health intervention for Alzheimer’s disease: Ability-TelerehABILITation trial
🖋️ F Rossetto, S Isernia, F Borgnis, et al.
📅 2023 | 🔗 Cited by: 15

🚀 Executive-functions innovative tool (EXIT 360): Usability and user experience study
🖋️ F Borgnis, F Baglio, E Pedroli, et al.
📅 2021 | 🔗 Cited by: 14

🎥 A simple and effective way to study executive functions using 360 videos
🖋️ F Borgnis, F Baglio, E Pedroli, et al.
📅 2021 | 🔗 Cited by: 14

🛠️ System Integrated Digital Empowering and TeleRehabilitation (SIDERA): Usability and acceptability study
🖋️ F Rossetto, F Borgnis, S Isernia, et al.
📅 2023 | 🔗 Cited by: 13

🏃 Functional improvement after multidisciplinary rehabilitation in Parkinson’s disease
🖋️ M Meloni, FL Saibene, S Di Tella, et al.
📅 2021 | 🔗 Cited by: 13

🎼 Modified graded motor imagery for musicians’ focal dystonia: a case series
🖋️ M Ramella, F Borgnis, et al.
📅 2021 | 🔗 Cited by: 13

📝 SIDERA^B Protocol: Randomized trial on digital health and rehabilitation
🖋️ F Rossetto, F Borgnis, et al.
📅 2022 | 🔗 Cited by: 10

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

 

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

 

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

 

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

 

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

 

Publication Top Notes  

  • A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
  • Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
  • An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
  • Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
  • Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
  • Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
  • The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
  • Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
  • Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
  • Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱